FDA Likely To Rule On Virus Pill In December

Washington, Oct 14 (AP) The Food and Drug Administration will ask its outside experts to meet in late November to scrutinise Merck’s pill to treat COVID-19. The November 30 meeting means US regulators likely won’t issue a decision on the drug until December, signalling that the agency will conduct a detailed review of the experimental treatment’s safety and effectiveness. The panelists are likely to vote on whether Merck’s drug should be approved, although the FDA is not required to follow their advice..

Source: Top India News- News18.com